Xylazine, heroin and drug markets with Caroline Copeland
Addiction Audio9 Huhti 2024

Xylazine, heroin and drug markets with Caroline Copeland

In this episode Ben Scher talks to Dr Caroline Copeland about her work analysing drug death data to identify drug use trends, harms and to inform policy. Caroline talks about how xylazine first entered the US drug market but has been increasingly identified in Europe and the UK, even being identified in vapes sold as containing tetrahydrocannabinol (THC). Caroline covers the harms from xylazine and the implications for public health practitioners before relating the UK issues to wider global drug markets.


"The other really nasty thing that xylazine does is that it can cause blood vessels to contract, and our tissues need blood.....to survive, and if we're closing off those blood vessels, that tissue is going to die and it's going to turn into sores on your skin. And if they get infected it can lead to amputation"


Dr Caroline Copeland is a senior lecturer in pharmacology and toxicology at King’s College London and the director of the National Programme on Substance Use Mortality.


Original article: Broad evidence of xylazine in the UK illicit drug market beyond heroin supplies, triangulating from toxicology, drug testing and law enforcement by Caroline Copeland and colleagues. Published in Addiction (2024)


The opinions expressed in this podcast reflect the views of the host and interviewees and do not necessarily represent the opinions or official positions of the SSA or Addiction journal.

The SSA does not endorse or guarantee the accuracy of the information in external sources or links and accepts no responsibility or liability for any consequences arising from the use of such information.

Hosted on Acast. See acast.com/privacy for more information.

Jaksot(112)

Alcohol and the pleasure of intoxication with James Nicholls

Alcohol and the pleasure of intoxication with James Nicholls

In this episode, Dr Elle Wadsworth talks to Dr James Nicholls from the University of Stirling about an opinion paper he co-authored with Professor Geoffrey Hunt on whether pleasure should receive more...

24 Tammi 202516min

Young people and disposable e-cigarettes with David Hammond

Young people and disposable e-cigarettes with David Hammond

In this episode Dr Elle Wadsworth talks to Professor David Hammond about vaping. They discuss policy differences between the Canada, the UK and the US as well as changes relating to disposable vapes a...

8 Elo 202422min

Opioids, cancer and mortality with Aleksi Hamina

Opioids, cancer and mortality with Aleksi Hamina

In this episode Ben Scher talks to Dr Aleksi Hamina from the Norwegian centre for addiction research at the University of Oslo and the Niuvanniemi Hospital in Finland. They discuss a recent paper co-a...

18 Heinä 202413min

Cannabis potency and psychotic experiences with Lindsey Hines

Cannabis potency and psychotic experiences with Lindsey Hines

In this episode, Dr Rob Calder talks to Dr Lindsey Hines about her study using longitudinal data to examine links between cannabis use, cannabis potency and psychotic experiences. Dr Hines talks about...

6 Kesä 202425min

Cannabis use in the US with Jonathan Caulkins

Cannabis use in the US with Jonathan Caulkins

In this episode Dr Elle Wadsworth talks to Professor Jonathan Caulkins about self-reported cannabis use in the US between 1979 and 2022 and how those trends compare with alcohol use over the same peri...

22 Touko 202422min

Integrated care vans with Kathleen Page

Integrated care vans with Kathleen Page

In this episode, Ben Scher talks to Dr Kathleen Page about her evaluation of an integrated care van that ran in Baltimore offering healthcare interventions and buprenorphine prescribing. Dr Page discu...

9 Touko 202426min

Smoking and abdominal obesity with Germán Carrasquilla

Smoking and abdominal obesity with Germán Carrasquilla

In this episode Rob Calder talks to Dr Germán Carrasquilla about his study assessing whether smoking cased increases in abdominal obesity or belly fat. They discuss the implications of this kind of fa...

2 Touko 202417min

Benzodiazepines and treatment with Adam Bakker, Michael Liebrenz and Alexander Smith

Benzodiazepines and treatment with Adam Bakker, Michael Liebrenz and Alexander Smith

In this episode Ben Scher talks to Dr Adam Bakker, Professor Michael Liebrenz and Dr Alexander Smith about their commentary in response to a previous paper by Domzaridou and colleages (2023). They dis...

25 Huhti 202423min

Suosittua kategoriassa Tiede

rss-mita-tulisi-tietaa
rss-poliisin-mieli
rss-lihavuudesta-podcast
utelias-mieli
rss-duodecim-lehti
tiedekulma-podcast
docemilia
mielipaivakirja
rss-ylistys-elaimille
rss-tervetta-skeptisyytta
koodikahvit
menologeja-tutkimusmatka-vaihdevuosiin
rss-ranskaa-raakana
rss-vaasan-yliopiston-podcastit
rss-metsa
rss-radplus
rss-tiedetta-vai-tarinaa